REMSleep Holdings (RMSL) Stock Analysis & Winston Score

Winston Score History

REMSleep Holdings is a small medical device company focused on helping people who have sleep apnea. Sleep apnea is a condition where people stop breathing briefly while they sleep, and it affects millions of people worldwide. The company is developing a product called the DeltaWave, which is designed as a more comfortable alternative to the standard CPAP mask that most sleep apnea patients currently use.

REMSleep generates little to no meaningful revenue at this stage, as the company is still in early development. It operates primarily in the United States and has an extremely small market presence, reflected in its near-zero market cap and deeply negative margins. The central risk for REMSleep is straightforward: the company must successfully complete product development, navigate regulatory approval from the FDA, and then compete against established medical device makers — all while continuing to fund operations with very limited financial resources.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+205.5% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

+200.0% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

3.1%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Runway

~0 months

$0 cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Short runway — potential dilution ahead through share issuance

Revenue accelerating

REMSleep Holdings grew revenue 206% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

50.0%

Healthy — 50.0% gross margin

Profit after running costs

Operating Margin

-246.1%

Losing money on operations — -246.1%

Return on the money invested

ROCE

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

-27.1%

Shrinking sales (-27.1% YoY)

Profit growth

EPS YoY

N/A

—

Data not available

How steady the profit is

EPS Consistency

3/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

Data not available

Spare cash per sale

FCF Margin

-1887851058.2%

Burning cash (-1887851058.2%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

N/A

Data not available

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial